BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 38355898)

  • 1. A cohort study of neurodevelopmental disorders and/or congenital anomalies using high resolution chromosomal microarrays in southern Brazil highlighting the significance of ASD.
    Chaves TF; Ocampos M; Barbato IT; de Camargo Pinto LL; de Luca GR; Barbato Filho JH; Bernardi P; Costa Netto Muniz Y; Francesca Maris A
    Sci Rep; 2024 Feb; 14(1):3762. PubMed ID: 38355898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long contiguous stretches of homozygosity detected by chromosomal microarrays (CMA) in patients with neurodevelopmental disorders in the South of Brazil.
    Chaves TF; Oliveira LF; Ocampos M; Barbato IT; de Luca GR; Barbato Filho JH; de Camargo Pinto LL; Bernardi P; Maris AF
    BMC Med Genomics; 2019 Mar; 12(1):50. PubMed ID: 30866944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copy Number Variations in a Cohort of 420 Individuals with Neurodevelopmental Disorders From the South of Brazil.
    Chaves TF; Baretto N; Oliveira LF; Ocampos M; Barbato IT; Anselmi M; De Luca GR; Barbato Filho JH; Pinto LLC; Bernardi P; Maris AF
    Sci Rep; 2019 Nov; 9(1):17776. PubMed ID: 31780800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of exome sequencing in individuals with large homozygous regions detected by chromosomal microarray analysis.
    Prasad A; Sdano MA; Vanzo RJ; Mowery-Rushton PA; Serrano MA; Hensel CH; Wassman ER
    BMC Med Genet; 2018 Mar; 19(1):46. PubMed ID: 29554876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
    Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
    Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
    Ho KS; Wassman ER; Baxter AL; Hensel CH; Martin MM; Prasad A; Twede H; Vanzo RJ; Butler MG
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine chromosomal microarray analysis is necessary in Korean patients with unexplained developmental delay/mental retardation/autism spectrum disorder.
    Shin S; Yu N; Choi JR; Jeong S; Lee KA
    Ann Lab Med; 2015 Sep; 35(5):510-8. PubMed ID: 26206688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Performance of an Ultrahigh Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
    Ho KS; Twede H; Vanzo R; Harward E; Hensel CH; Martin MM; Page S; Peiffer A; Mowery-Rushton P; Serrano M; Wassman ER
    Biomed Res Int; 2016; 2016():3284534. PubMed ID: 27975050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal Aberrations in Pediatric Patients with Developmental Delay/Intellectual Disability: A Single-Center Clinical Investigation.
    Hu T; Zhang Z; Wang J; Li Q; Zhu H; Lai Y; Wang H; Liu S
    Biomed Res Int; 2019; 2019():9352581. PubMed ID: 31781653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long contiguous stretches of homozygosity spanning shortly the imprinted loci are associated with intellectual disability, autism and/or epilepsy.
    Iourov IY; Vorsanova SG; Korostelev SA; Zelenova MA; Yurov YB
    Mol Cytogenet; 2015; 8():77. PubMed ID: 26478745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epigenomic variations manifesting as a loss of heterozygosity affecting imprinted genes represent a molecular mechanism of autism spectrum disorders and intellectual disability in children].
    Iourov IY; Vorsanova SG; Zelenova MA; Vasin KS; Kurinnaia OS; Korostelev SA; Yurov YB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(5):91-97. PubMed ID: 31317896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights in the interpretation of array-CGH: autism spectrum disorder and positive family history for intellectual disability predict the detection of pathogenic variants.
    Cappuccio G; Vitiello F; Casertano A; Fontana P; Genesio R; Bruzzese D; Ginocchio VM; Mormile A; Nitsch L; Andria G; Melis D
    Ital J Pediatr; 2016 Apr; 42():39. PubMed ID: 27072107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea.
    Jang W; Kim Y; Han E; Park J; Chae H; Kwon A; Choi H; Kim J; Son JO; Lee SJ; Hong BY; Jang DH; Han JY; Lee JH; Kim SY; Lee IG; Sung IK; Moon Y; Kim M; Park JH
    Ann Lab Med; 2019 May; 39(3):299-310. PubMed ID: 30623622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLPA is a practical and complementary alternative to CMA for diagnostic testing in patients with autism spectrum disorders and identifying new candidate CNVs associated with autism.
    Capkova P; Srovnal J; Capkova Z; Staffova K; Becvarova V; Trkova M; Adamova K; Santava A; Curtisova V; Hajduch M; Prochazka M
    PeerJ; 2019; 6():e6183. PubMed ID: 30647996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal microarray in postnatal diagnosis of congenital anomalies and neurodevelopmental disorders in Serbian patients.
    Perovic D; Damnjanovic T; Jekic B; Dusanovic-Pjevic M; Grk M; Djuranovic A; Rasic M; Novakovic I; Maksimovic N
    J Clin Lab Anal; 2022 Jun; 36(6):e24441. PubMed ID: 35441737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal microarray analyses from 5778 patients with neurodevelopmental disorders and congenital anomalies in Brazil.
    Krepischi ACV; Villela D; da Costa SS; Mazzonetto PC; Schauren J; Migliavacca MP; Milanezi F; Santos JG; Guida G; Guarischi-Sousa R; Campana G; Kok F; Schlesinger D; Kitajima JP; Campagnari F; Bertola DR; Vianna-Morgante AM; Pearson PL; Rosenberg C
    Sci Rep; 2022 Sep; 12(1):15184. PubMed ID: 36071085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility and cost-effectiveness analysis of chromosome testing concomitant with chromosomal microarray of patients with constitutional disorders in a U.S. academic medical center.
    Su M; Page S; Haag M; Swisshelm K; Hennerich D; Graw S; LeRoux J; Brzeskiewicz P; Svihovec S; Bao L
    J Genet Couns; 2022 Apr; 31(2):364-374. PubMed ID: 34397147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution chromosomal microarray analysis for copy-number variations in high-functioning autism reveals large aberration typical for intellectual disability.
    Werling AM; Grünblatt E; Oneda B; Bobrowski E; Gundelfinger R; Taurines R; Romanos M; Rauch A; Walitza S
    J Neural Transm (Vienna); 2020 Jan; 127(1):81-94. PubMed ID: 31838600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of chromosomal microarrays in the evaluation of intellectual disability/global developmental delay patients - A study from a tertiary care genetic centre in India.
    Sharma P; Gupta N; Chowdhury MR; Sapra S; Ghosh M; Gulati S; Kabra M
    Gene; 2016 Sep; 590(1):109-19. PubMed ID: 27291820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare recurrent copy number variations in metabotropic glutamate receptor interacting genes in children with neurodevelopmental disorders.
    Glessner JT; Khan ME; Chang X; Liu Y; Otieno FG; Lemma M; Slaby I; Hain H; Mentch F; Li J; Kao C; Sleiman PMA; March ME; Connolly J; Hakonarson H
    J Neurodev Disord; 2023 Apr; 15(1):14. PubMed ID: 37120522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.